Studying a modern Gamified Study for diabetes self-care

Improving diabetes health symptoms by using a specialized VR gamification self-care method: A parallel-group randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20260317068997N1

Enrollment

Registered

2026-04-11

Start date

2024-11-21

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes. Type 1 diabetes mellitus

Interventions

Intervention 1: Intervention group 1 (VR gamified group): A virtual reality–based gamification intervention designed to enhance diabetes self-care behaviors (physical activity, dietary adherence, and

Eligibility

Sex/Gender

All

Age

7 Years to 15 Years

Inclusion criteria

Inclusion criteria: Formal Diagnosis of Diabetes Willingness to participate in a six week self-care program Age Range between 7-15

Exclusion criteria

Exclusion criteria: Medical conditions that prevent VR headset use

Design outcomes

Primary

Measure	Time frame
Weekly average daily monitored fast blood sugar (FBS). Timepoint: Monitoring was conducted at baseline and then weekly for five weeks after the start of the study. Method of measurement: Participants measured their fasting blood sugar levels every morning using a personal glucometer and self reported the values. The recorded daily FBS values were then used by the experimenters to calculate a weekly average for each participant.;Weekly sum of daily calculated physical activity (PA). Timepoint: Monitoring was conducted at baseline and then weekly for five weeks after the start of the study. Method of measurement: Physical activity was quantified using a bar metric: one bar equaled either 30 minutes of vigorous activity (e.g., gym workouts or swimming) or 60 minutes of moderate activity (e.g., jogging). The weekly sum was calculated based on this definition.;Weekly average daily calculated food intake (daily calories). Timepoint: Monitoring was conducted at baseline and then weekly for five weeks after the start of the study. Method of measurement: Participants either reported their total daily caloric intake directly or reported their food descriptions, from which caloric values were estimated. A weekly average of daily caloric intake was then computed.;Weekly calculated BMI. Timepoint: Monitoring was conducted at baseline and then weekly for five weeks after the start of the study. Method of measurement: Participants self-reported their weight on a weekly basis. BMI was calculated using the standard formula: weight (kg) divided by height squared (m²), which had been reported at first.;HbA1c pre-test and post-test. Timepoint: Monitoring was done, once before the beginning of the trial, and once, after the end of the trial. Method of measurement: HbA1c levels were measured twice via laboratory blood tests: once before the intervention (pre-test) and once at the conclusion of the study (post-test), serving as a long-term indicator of blood glucose control.	—

Measure

Time frame

Weekly average daily monitored fast blood sugar (FBS). Timepoint: Monitoring was conducted at baseline and then weekly for five weeks after the start of the study. Method of measurement: Participants measured their fasting blood sugar levels every morning using a personal glucometer and self reported the values. The recorded daily FBS values were then used by the experimenters to calculate a weekly average for each participant.;Weekly sum of daily calculated physical activity (PA). Timepoint: Monitoring was conducted at baseline and then weekly for five weeks after the start of the study. Method of measurement: Physical activity was quantified using a bar metric: one bar equaled either 30 minutes of vigorous activity (e.g., gym workouts or swimming) or 60 minutes of moderate activity (e.g., jogging). The weekly sum was calculated based on this definition.;Weekly average daily calculated food intake (daily calories). Timepoint: Monitoring was conducted at baseline and then weekly for five weeks after the start of the study. Method of measurement: Participants either reported their total daily caloric intake directly or reported their food descriptions, from which caloric values were estimated. A weekly average of daily caloric intake was then computed.;Weekly calculated BMI. Timepoint: Monitoring was conducted at baseline and then weekly for five weeks after the start of the study. Method of measurement: Participants self-reported their weight on a weekly basis. BMI was calculated using the standard formula: weight (kg) divided by height squared (m²), which had been reported at first.;HbA1c pre-test and post-test. Timepoint: Monitoring was done, once before the beginning of the trial, and once, after the end of the trial. Method of measurement: HbA1c levels were measured twice via laboratory blood tests: once before the intervention (pre-test) and once at the conclusion of the study (post-test), serving as a long-term indicator of blood glucose control.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactJavad Hatami

Psychology Department, Tehran University

hatamijm@ut.ac.ir+98 21 6111 2198

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026